Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0492-7
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2016 AND VI 18 AND IP 1
Results: 7
1
2
Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0490-9
- By:
- Publication type:
- Article
3
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0489-2
- By:
- Publication type:
- Article
4
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0485-6
- By:
- Publication type:
- Article
5
Robotic Surgery for Colon and Rectal Cancer.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 5, doi. 10.1007/s11912-015-0491-8
- By:
- Publication type:
- Article
6
The Epidemiology of Male Breast Cancer.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0487-4
- By:
- Publication type:
- Article
7
State of the Art Antiemetic Therapy for Cancer Patients.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11912-015-0486-5
- By:
- Publication type:
- Article